Rachel Schilke is a congressional reporter at the Washington Examiner, where she was previously a breaking news reporter. Originally from Frankfort, Illinois, she graduated from the University of ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Eli Lilly’s acquisition of gene therapy specialist Akouos seems to have paid off, after the lead candidate in the deal restored hearing in a child with congenital deafness. The AK-OTOF therapy ...

The Itel S42 offers quite a few premium features and specifications, and looks pretty good. Buyers might be tempted by the 3GB of RAM, 18:9 HD+ screen, selfie flash, up-to-date Android security ...

Sign up for announcements and exclusive discounts on tickets to your favorite shows!